David Hughes,
Chief Technical Officer
Dr David Hughes is the Chief Technical Officer at CN Bio Innovations. Dr Hughes graduated with an MEng and DPhil from the University of Oxford in Chemical Engineering. After 4 years in Research and Development at GlaxoSmithKline he joined CN Bio Innovations (formerly Zyoxel Ltd) to lead commercialization efforts on their organ-on-a-chip technologies. He is a co-PI on the Physiomimetics consortium which is headed by Prof L. Griffith at M.I.T and funded by a $26million dollar DARPA award from the Microphysiological Systems program, more commonly referred to as the human-body-on-a-chip program. Dr Hughes has also lead EU Framework 7 and Technology Strategy Board (now Innovate UK) projects to develop organ-on-a-chip models for fatty liver disease and mono-genetic liver disorder.
|
|
|
